About

China's IVD market, valued at $16.6 billion in 2023, shows growth potential across various segments, including molecular diagnostics, point-of-care testing, immunoassay, hematology, pathology, microbiology, and clinical biochemicals.

This webinar will provide an overview of China's IVD market, highlighting market opportunities, access requirements, IP considerations, and the latest regulatory updates.

Who should join this webinar?
- Innovative medical equipment/device and IVD manufacturers
- IVD test kits / IVD equipment manufacturers
- Laboratory service providers
- MedTech product Intellectual Property owners and attorneys
- International market access and regulatory managers
- Overseas sales and marketing directors

Agenda & Speakers
-Moderator: Kerry Barnett, Global Healthcare Team Leader, U.S. Commercial Service

-Welcome Remarks, Jade Sims, Commercial Officer, U.S. Embassy Beijing (5')
  

-IP Protection in China, Juli Schwartz, IP Attaché, United States Patent and Trademark  Office, U.S. Consulate General Shanghai (10')

-New Trends and Marketing Strategies in China IVD Market, Karen Dai, Executive 
General Secretary of China Association of In-Vitro Diagnostics (10')

-Overview of the IVD Market in China, Edwina Dong, IVD Senior Consultant, IQVIA (15')

-NMPA Regulatory Requirements and Registration Pathway, Grace Fu Palma, Principal,  China Med Device, LLC (10')

-CACLP 2025 Introduction, Tiki Wang, Marketing Specialist of CACLP(10')

-Q&A (10')

LEARN ABOUT OUR EVENTS

We invite you to explore the wide variety of events that we offer to help U.S. companies expand their global sales.


Speakers
Edwina Dong Speaker image
Grade Fu Palma Speaker image
Jade Sims, U.S. Embassy, Beijing Speaker image
Juli Schwartz Speaker image
Karen Dai, General Manager of CACLP Speaker image
Kerry Barnett (Moderator) Speaker image
Tiki Wang Speaker image